General aspects of muscle glucose uptake

Anais da Academia Brasileira de Ciencias

Volumn 87, Issue 1, 2015, Pages 351-368

  Alvim, Rafael O ^a   Cheuhen, Marcel R ^a   Machado, Silmara R ^b   Sousa, André Gustavo P ^a,c   Santos, Paulo C J L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL SÍRIO LIBANÊS   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

Diabetes; Diet; Exercise; Glucose uptake; Hypoglycemic drugs

Indexed keywords

GLUCOSE;

EXERCISE; HUMAN; INSULIN RESISTANCE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; EXERCISE; GLUCOSE; HUMANS; INSULIN RESISTANCE; MUSCLE, SKELETAL; SIGNAL TRANSDUCTION;

EID: 84925954949     PISSN: 00013765     EISSN: 16782690     Source Type: Journal    
DOI: 10.1590/0001-3765201520140225     Document Type: Article

References (157)

1. ABRAHAMSON MJ. 2003. Clinical use of thiazolidinediones: recommendations. Am J Med 115 Suppl 8A: 116S-120S.
2. ALDEA M, TOMULEASA C, PETRUSHEV B, SUSMAN S, KACSO GI, IRIMIE A, FLORIAN IS AND SORITAU O. 2011. Antidiabetic pharmacology: a link between metabolic syndrome and neuro-oncology? J BUON 16: 409-413.
3. AL-MALLAH M, KHAWAJA O, SINNO M, ALZOHAILI O AND SAMRA AB. 2010. Do angiotensin converting enzyme inhibitors or angiotensin receptor blockers prevent diabetes mellitus? A meta-analysis. Cardiol J 17: 448-456.
4. AN D, TOYODA T, TAYLOR EB, YU H, FUJII N, HIRSHMAN MF AND GOODYEAR LJ. 2010. TBC1D1 regulates insulin- and contraction-induced glucose transport in mouse skeletal muscle. Diabetes 59: 1358-1365.
5. BACKER JM ET AL. 1992. Phosphatidylinositol 3'-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J 11: 3469-3479.
6. BANKS EA, BROZINICK Jr JT, YASPELKIS BB, 3RD, KANG HY AND IVY JL. 1992. Muscle glucose transport, GLUT-4 content, and degree of exercise training in obese Zucker rats. Am J Physiol 263: E1010-1015.
7. BARNES BR ET AL. 2004. The 5'-AMP-activated protein kinase gamma3 isoform has a key role in carbohydrate and lipid metabolism in glycolytic skeletal muscle. J Biol Chem 279: 38441-38447.
8. BELDA-INIESTA C, PERNIA O AND SIMO R. 2011. Metformin: a new option in cancer treatment. Clin Transl Oncol 13: 363-367.
9. BENNETT WL, ODELOLA OA, WILSON LM, BOLEN S, SELVARAJ S, ROBINSON KA,BASS EB ANDPUHAN MA, Evaluation of guideline recommendations on oral medications for type 2 diabetes mellitus: a systematic review. 2012. Ann Intern Med 156: 27-36.
10. BERGERON R, RUSSELL RR3RD,YOUNG LH, REN JM, MARCUCCI M, LEE A AND SHULMAN GI, Effect of AMPK activation on muscle glucose metabolism in conscious rats.. 1999. Am J Physiol 276: E938-944.
11. BOUSKILA M, HUNTER RW, IBRAHIM AF, DELATTRE L, PEGGIE M, VAN DIEPEN JA, VOSHOL PJ,JENSEN J AND SAKAMOTO K, Allosteric regulation of glycogen synthase controls glycogen synthesis in muscle. 2010. Cell Metab 12: 456-466.
12. BRADLEY SJ,KINGWELL BA AND MCCONELL GK, Nitric oxide synthase inhibition reduces leg glucose uptake but not blood flow during dynamic exercise in humans. 1999. Diabetes 48: 1815-1821.
13. BROZINICK Jr JT, ETGEN Jr GJ, YASPELKIS BB3RD,KANG HY AND IVY JL, Effects of exercise training on muscle GLUT-4 protein content and translocation in obese Zucker rats. 1993. Am J Physiol 265: E419-427.
14. BRUSS MD, ARIAS EB,LIENHARD GE AND CARTEE GD, Increased phosphorylation of Akt substrate of 160 kDa (AS160) in rat skeletal muscle in response to insulin or contractile activity. 2005. Diabetes 54: 41-50.
15. CARTEE GD AND HOLLOSZY JO. 1990. Exercise increases susceptibility of muscle glucose transport to activation by various stimuli. Am J Physiol 258: E390-393.
16. CAVALHEIRA JBC,ZECCHIN HG AND SAAD MJA, Vias de sinalização da insulina. 2002. Arq Bras Endocrinol Metab 46: 419-425.
17. CHEN ZP, MCCONELL GK, MICHELL BJ, SNOW RJ,CANNY BJ AND KEMP BE, AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. 2000. Am J Physiol Endocrinol Metab 279: E1202-1206.
18. CHIN ER. 2005. Role of Ca2+/calmodulin-dependent kinases in skeletal muscle plasticity. J Appl Physiol 99: 414-423.
19. CORTEZ MY, TORGAN CE, BROZINICK Jr JT, AND IVY JL. 1991. Insulin resistance of obese Zucker rats exercise trained at two different intensities. Am J Physiol 261: E613-619.
20. CUSI K, MAEZONO K, OSMAN A, PENDERGRASS M, PATTI ME, PRATIPANAWATR T, DEFRONZO RA,KAHN CR ANDMANDARINO LJ, Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. 2000. J Clin Invest 105: 311-320.
21. DELA F, LARSEN JJ, MIKINES KJ, PLOUG T,PETERSEN LN ANDGALBO H, Insulin-stimulated muscle glucose clearance in patients with NIDDM. Effects of one-legged physical training. 1995. Diabetes 44: 1010-1020.
22. DONG LQ AND LIU F. 2005. PDK2: the missing piece in the receptor tyrosine kinase signaling pathway puzzle. Am J Physiol Endocrinol Metab 289: E187-196.
23. DRAZNIN B. 2006. Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression of p85alpha: the two sides of a coin. Diabetes 55: 2392-2397.
24. DRUCKER DJ, SHERMAN SI,BERGENSTAL RM AND BUSE JB, The safety of incretin-based therapies-review of the scientific evidence. 2011. J Clin Endocrinol Metab 96: 2027-2031.
25. DUKA I, SHENOUDA S, JOHNS C, KINTSURASHVILI E,GAVRAS I AND GAVRAS H, Role of the B(2) receptor of bradykinin in insulin sensitivity. 2001. Hypertension 38: 1355-1360.
26. DUMKE CL, KIM J,ARIAS EB AND CARTEE GD, Role of kallikrein-kininogen system in insulin-stimulated glucose transport after muscle contractions. 2002. J Appl Physiol 92: 657-664.
27. EGAWA T, HAMADA T, MA X, KARAIKE K, KAMEDA N, MASUDA S,IWANAKA N ANDHAYASHI T, Caffeine activates preferentially alpha1-isoform of 5'AMP-activated protein kinase in rat skeletal muscle. 2011. Acta Physiol (Oxf) 201: 227-238.
28. ERICKSON Jr AND ME. ANDERSON 2008. CaMKII and its role in cardiac arrhythmia. J Cardiovasc Electrophysiol 19: 1332-1336.
29. ERIKSSON JG. 1999. Exercise and the treatment of type 2 diabetes mellitus. An update. Sports Med 27: 381-391.
30. ETGEN Jr GJ,FRYBURG DA ANDGIBBS EM, Nitric oxide stimulates skeletal muscle glucose transport through a calcium/contraction- and phosphatidylinositol-3-kinaseindependent pathway. 1997. Diabetes 46: 1915-1919.
31. FEDIUC S,GAIDHU MP ANDCEDDIA RB, Inhibition of insulin-stimulated glycogen synthesis by 5-aminoimidasole4-carboxamide-1-beta-d-ribofuranoside-induced adenosine 5'-monophosphate-activated protein kinase activation: interactions with Akt, glycogen synthase kinase 3-3alpha/ beta, and glycogen synthase in isolated rat soleus muscle. 2006. Endocrinology 147: 5170-5177.
32. FISHER JS, JU JS, OPPELT PJ, SMITH JL,SUZUKI A AND ESUMI H, Muscle contractions, AICAR, and insulin cause phosphorylation of an AMPK-related kinase. 2005. Am J Physiol Endocrinol Metab 289: E986-992.
33. FRODIN M, ANTAL TL, DUMMLER BA, JENSEN CJ, DEAK M,GAMMELTOFT S AND BIONDI RM, A phosphoserine/ threonine-binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation. 2002. EMBO J 21: 5396-5407.
34. FUJII N ET AL. 2000. Exercise induces isoform-specific increase in 5'AMP-activated protein kinase activity in human skeletal muscle. Biochemical and biophysical research communications 273: 1150-1155.
35. FUJII N, HIRSHMAN MF, KANE EM, HO RC, PETER LE,SEIFERT MM AND GOODYEAR LJ, AMP-activated protein kinase alpha2 activity is not essential for contraction- and hyperosmolarity-induced glucose transport in skeletal muscle. 2005. J Biol Chem 280: 39033-39041.
36. GAMBOA JL,,GARCIA-CAZARIN ML AND ANDRADE FH 2011. Chronic hypoxia increases insulin-stimulated glucose uptake in mouse soleus muscle. Am J Physiol Regul Integr Comp Physiol 300: R85-91.
37. GOODYEAR LJ, HIRSHMAN MF,VALYOU PM AND HORTON ES, Glucose transporter number, function, and subcellular distribution in rat skeletal muscle after exercise training. 1992. Diabetes 41: 1091-1099.
38. GOODYEAR LJ, KING PA, HIRSHMAN MF, THOMPSON CM, HORTON ED AND HORTON ES. 1990. Contractile activity increases plasma membrane glucose transporters in absence of insulin. Am J Physiol 258: E667-672.
39. GUILLAUSSEAU PJ, MEAS T, VIRALLY M, M LALOI-MICHELIN,MEDEAU V AND KEVORKIAN JP, Abnormalities in insulin secretion in type 2 diabetes mellitus. 2008. Diabetes Metab 34 Suppl 2: S43-48.
40. HALLSTEN K, VIRTANEN KA, LONNQVIST F, SIPILA H, OKSANEN A, VILJANEN T, RONNEMAA T, VIIKARI J, KNUUTI J AND NUUTILA P. 2002. Rosiglitazone but not metformin enhances insulin- and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes. Diabetes 51: 3479-3485.
41. HAMM JK, EL JACK AK,PILCH PF AND FARMER SR, Role of PPAR gamma in regulating adipocyte differentiation and insulin-responsive glucose uptake. 1999. Ann N Y Acad Sci 892: 134-145.
42. HARDIE DG. 2003. Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology 144: 5179-5183.
43. HARDIE DG. 2008. AMPK: a key regulator of energy balance in the single cell and the whole organism. Int J Obes (Lond) 32 Suppl 4: S7-12.
44. HARDIE DG AND SAKAMOTO K. 2006. AMPK: a key sensor of fuel and energy status in skeletal muscle. Physiology (Bethesda) 21: 48-60.
45. HARDIE DG, SCOTT JW,PAN DA AND HUDSON ER, Management of cellular energy by the AMP-activated protein kinase system. 2003. FEBS Lett 546: 113-120.
46. HAYASHI T, HIRSHMAN MF, KURTH EJ,WINDER WW AND GOODYEAR LJ, Evidence for 5' AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. 1998. Diabetes 47: 1369-1373.
47. HAYASHI T,WOJTASZEWSKI JF AND GOODYEAR LJ, Exercise regulation of glucose transport in skeletal muscle.. 1997. Am J Physiol 273: E1039-1051.
48. HEINONEN I, NESTEROV SV, KEMPPAINEN J, FUJIMOTO T,KNUUTI J AND KALLIOKOSKI KK, Increasing exercise intensity reduces heterogeneity of glucose uptake in human skeletal muscles. 2012. PLoS One 7: e52191.
49. HENRIKSEN EJ, JACOB S,FOGT DL AND DIETZE GJ, Effect of chronic bradykinin administration on insulin action in an animal model of insulin resistance. 1998. Am J Physiol 275: R40-45.
50. HENSTRIDGE DC, DREW BG, FORMOSA MF, NATOLI AK,CAMERON-SMITH D, DUFFY SJ AND KINGWELL BA, The effect of the nitric oxide donor sodium nitroprusside on glucose uptake in human primary skeletal muscle cells. 2009. Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society 21: 126-131.
51. HEVENER AL,REICHART D AND OLEFSKY J, Exercise and thiazolidinedione therapy normalize insulin action in the obese Zucker fatty rat. 2000. Diabetes 49: 2154-2159.
52. HIGAKI Y, HIRSHMAN MF,FUJII N AND GOODYEAR LJ, Nitric oxide increases glucose uptake through a mechanism that is distinct from the insulin and contraction pathways in rat skeletal muscle. 2001. Diabetes 50: 241-247.
53. HOLLOSZY JO AND HANSEN PA. 1996. Regulation of glucose transport into skeletal muscle. Rev Physiol Biochem Pharmacol 128: 99-193.
54. HUGHES VA, FIATARONE MA, FIELDING RA, KAHN BB, FERRARA CM, SHEPHERD P, FISHER EC, WOLFE RR,ELAHI D AND EVANS WJ, Exercise increases muscle GLUT-4 levels and insulin action in subjects with impaired glucose tolerance. 1993. Am J Physiol 264: E855-862.
55. IVY JL,ZDERIC TW AND FOGT DL, Prevention and treatment of non-insulin-dependent diabetes mellitus. 1999. Exerc Sport Sci Rev 27: 1-35.
56. JACKSON MJ. 2008. Free radicals generated by contracting muscle: by-products of metabolism or key regulators of muscle function? Free Radic Biol Med 44: 132-141.
57. JENSEN TE, ROSE AJ, HELLSTEN Y,WOJTASZEWSKI JF AND RICHTER EA, Caffeine-induced Ca(2+) release increases AMPK-dependent glucose uptake in rodent soleus muscle. 2007a. Am J Physiol Endocrinol Metab 293: E286-292.
58. JENSEN TE, ROSE AJ, JORGENSEN SB, BRANDT N, SCHJERLING P,WOJTASZEWSKI JF AND RICHTER EA, Possible CaMKK-dependent regulation of AMPK phosphorylation and glucose uptake at the onset of mild tetanic skeletal muscle contraction. 2007b. Am J Physiol Endocrinol Metab 292: E1308-1317.
59. JENSEN TE, SCHJERLING P, VIOLLET B,WOJTASZEWSKI JF AND RICHTER EA, AMPK alpha1 activation is required for stimulation of glucose uptake by twitch contraction, but not by H2O2, in mouse skeletal muscle. 2008. PLoS One 3: e2102.
60. JESSEN N AND GOODYEAR LJ. 2005. Contraction signaling to glucose transport in skeletal muscle. J Appl Physiol 99: 330-337.
61. JI LL. 2008. Modulation of skeletal muscle antioxidant defense by exercise: Role of redox signaling. Free Radic Biol Med 44: 142-152.
62. JORGE ML ET AL. 2011. The effects of aerobic, resistance, and combined exercise on metabolic control, inflammatory markers, adipocytokines, and muscle insulin signaling in patients with type 2 diabetes mellitus. Metabolism 60: 1244-1252.
63. JORGENSEN SB, VIOLLET B, ANDREELLI F, FROSIG C, BIRK JB, SCHJERLING P, VAULONT S,RICHTER EA AND WOJTASZEWSKI JF, Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. 2004. J Biol Chem 279: 1070-1079.
64. JU JS, GITCHO MA, CASMAER CA, PATIL PB, HAN DG,SPENCER SA AND FISHER JS, Potentiation of insulinstimulated glucose transport by the AMP-activated protein kinase. 2007. Am J Physiol Cell Physiol 292: C564-572.
65. KADOGLOU NP, ILIADIS F, ANGELOPOULOU N, PERREA D, AMPATZIDIS G,LIAPIS CD AND ALEVIZOS M, The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus. 2007. Eur J Cardiovasc Prev Rehabil: official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 14: 837-843.
66. KANE S, SANO H, LIU SC, ASARA JM, LANE WS,GARNER CC AND LIENHARD GE, A method to identify serine kinase substrates. Akt phosphorylates a novel adipocyte protein with a Rab GTPase-activating protein (GAP) domain. 2002. J Biol Chem 277: 22115-22118.
67. KANG L, DUNN-MEYNELL AA, ROUTH VH, GASPERS LD, NAGATA Y, NISHIMURA T, EIKI J,ZHANG BB AND LEVIN BE, Glucokinase is a critical regulator of ventromedial hypothalamic neuronal glucosensing. 2006. Diabetes 55: 412-420.
68. KATZ A. 2007. Modulation of glucose transport in skeletal muscle by reactive oxygen species. J Appl Physiol 102: 1671-1676.
69. KAWAMORI R ET AL. 1998. Pioglitazone enhances splanchnic glucose uptake as well as peripheral glucose uptake in noninsulin-dependent diabetes mellitus. AD-4833 Clamp-OGL Study Group. Diabetes Res Clin Pract 41: 35-43.
70. KEMP BE ET AL. 2003. AMP-activated protein kinase, super metabolic regulator. Biochem Soc Trans 31: 162-168.
71. KENNEDY JW, HIRSHMAN MF, GERVINO EV, OCEL JV, FORSE RA, HOENIG SJ, ARONSON D,GOODYEAR LJ AND HORTON ES, Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes. 1999. Diabetes 48: 1192-1197.
72. KING PA, BETTS JJ, HORTON ED ANDHORTON ES. 1993. Exercise, unlike insulin, promotes glucose transporter translocation in obese Zucker rat muscle. Am J Physiol 265: R447-452.
73. KIRWAN JP ANDDEL AGUILA LF. 2003. Insulin signalling, exercise and cellular integrity. Biochemical Society transactions 31: 1281-1285.
74. KISHI K, MUROMOTO N, NAKAYA Y, MIYATA I, HAGI A,HAYASHI H AND EBINA Y, Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway. 1998. Diabetes 47: 550-558.
75. KNOWLER WC, E BARRETT-CONNOR, FOWLER SE, HAMMAN RF, LACHIN JM,WALKER EA AND NATHAN DM, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. 2002. N Engl J Med 346: 393-403.
76. KOHN AD, BARTHEL A, KOVACINA KS, BOGE A, WALLACH B, SUMMERS SA, BIRNBAUM MJ, SCOTT PH, LAWRENCE Jr JC AND ROTH RA 1998. Construction and characterization of a conditionally active version of the serine/threonine kinase Akt. J Biol Chem 273: 11937-11943.
77. KOISTINEN HA, GALUSKA D, CHIBALIN AV, YANG J, ZIERATH JR,HOLMAN GD ANDWALLBERG-HENRIKSSON H, 2003. 5-amino-imidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with type 2 diabetes. Diabetes 52: 1066-1072.
78. KRAMER HF, WITCZAK CA, FUJII N, JESSEN N, TAYLOR EB, ARNOLDS DE, SAKAMOTO K,HIRSHMAN MF AND GOODYEAR LJ, Distinct signals regulate AS160 phosphorylation in response to insulin, AICAR, and contraction in mouse skeletal muscle. 2006. Diabetes 55: 2067-2076.
79. KRENTZ AJ ANDBAILEY CJ. 2005. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs 65: 385-411.
80. EJ KURTH-KRACZEK, HIRSHMAN MF,GOODYEAR LJ ANDWINDER WW, 1999. 5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 48: 1667-1671.
81. LEE AD,HANSEN PA AND HOLLOSZY JO, Wortmannin inhibits insulin-stimulated but not contraction-stimulated glucose transport activity in skeletal muscle. 1995. FEBS Lett 361: 51-54.
82. LI M, VERDIJK LB, SAKAMOTO K, ELY B,VAN LOON LJ AND MUSI N, Reduced AMPK-ACC and mTOR signaling in muscle from older men, and effect of resistance exercise. 2012. Mech Ageing Dev 133: 655-664.
83. LIM J, ZHOU M,VEENSTRA TD AND MORRISON DK, The CNK1 scaffold binds cytohesins and promotes insulin pathway signaling. 2010. Genes Dev 24: 1496-1506.
84. LUND S, HOLMAN GD,SCHMITZ O AND PEDERSEN O, Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin. 1995. Proc Natl Acad Sci U S A 92: 5817-5821.
85. MACKENZIE R, ELLIOTT B, MAXWELL N, BRICKLEY G AND WATT P. 2012. The effect of hypoxia and work intensity on insulin resistance in type 2 diabetes. J Clin Endocrinol Metab 97: 155-162.
86. MATSAKAS A ANDPATEL K. 2009. Skeletal muscle fibre plasticity in response to selected environmental and physiological stimuli. Histol Histopathol 24: 611-629.
87. MCMURRAY RG AND HACKNEY AC. 2005. Interactions of metabolic hormones, adipose tissue and exercise. Sports Med 35: 393-412.
88. MERRY TL, LYNCH AND GS MCCONELL 2010a. GK. Downstream mechanisms of nitric oxide-mediated skeletal muscle glucose uptake during contraction. Am J Physiol Regul Integr Comp Physiol 299: R1656-1665.
89. MERRY TL ANDMCCONELL GK. 2012. Do Reactive Oxygen Species Regulate Skeletal Muscle Glucose Uptake During Contraction? Exerc Sport Sci Rev.
90. MERRY TL, STEINBERG GR,LYNCH GS AND MCCONELL GK, Skeletal muscle glucose uptake during contraction is regulated by nitric oxide and ROS independently of AMPK. 2010b. Am J Physiol Endocrinol Metab 298: E577-585.
91. MERRY TL, WADLEY GD, STATHIS CG, GARNHAM AP, RATTIGAN S,HARGREAVES M AND MCCONELL GK, N-Acetylcysteine infusion does not affect glucose disposal during prolonged moderate-intensity exercise in humans. 2010c. J Physiol 588: 1623-1634.
92. MILBURN CC, DEAK M, KELLY SM, PRICE NC,ALESSI DR AND VAN AALTEN DM, Binding of phosphatidylinositol 3,4,5-trisphosphate to the pleckstrin homology domain of protein kinase B induces a conformational change. 2003. Biochem J 375: 531-538.
93. MINOKOSHI Y ET AL. 2004. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428: 569-574.
94. MISRA A,SINGHAL N AND KHURANA L, Obesity, the metabolic syndrome, and type 2 diabetes in developing countries: role of dietary fats and oils. 2010. J Am Coll Nutr 29: 289S-301S.
95. MIYAMOTO L ET AL. 2007. Effect of acute activation of 5'-AMPactivated protein kinase on glycogen regulation in isolated rat skeletal muscle. J Appl Physiol 102: 1007-1013.
96. MONCADA S AND HIGGS A. 1993. The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002-2012.
97. MOR V AND UNNIKRISHNAN MK. 2011. 5'-adenosine monophosphate-activated protein kinase and the metabolic syndrome. Endocr Metab Immune Disord Drug Targets 11: 206-216.
98. MOTOSHIMA H ET AL. 2000. Bradykinin enhances insulin receptor tyrosine kinase in 32D cells reconstituted with bradykinin and insulin signaling pathways. Diabetes Res Clin Pract 48: 155-170.
99. MU J, BROZINICK Jr JT, VALLADARES O,BUCAN M AND BIRNBAUM MJ, A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. 2001. Mol Cell 7: 1085-1094.
100. MUSI N AND GOODYEAR LJ. 2003. AMP-activated protein kinase and muscle glucose uptake. Acta Physiol Scand 178: 337-345.
101. MUSI N ET AL. 2002. Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes 51: 2074-2081.
102. NARKAR VA ET AL. 2008. AMPK and PPARdelta agonists are exercise mimetics. Cell 134: 405-415.
103. NATALI A AND FERRANNINI E. 2006. Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review. Diabetologia 49: 434-441.
104. NISSEN SE AND WOLSKI K. 2007. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356: 2457-2471.
105. NORRIS SM, BOMBARDIER E, SMITH IC,VIGNA C AND TUPLING AR, ATP consumption by sarcoplasmic reticulum Ca2+ pumps accounts for 50% of resting metabolic rate in mouse fast and slow twitch skeletal muscle. 2012. Am J Physiol Cell Physiol 298: C521-529.
106. OJUKA EO. 2004. Role of calcium and AMP kinase in the regulation of mitochondrial biogenesis and GLUT4 levels in muscle. Proc Nutr Soc 63: 275-278.
107. OJUKA EO, JONES TE, NOLTE LA, CHEN M, WAMHOFF BR,STUREK M AND HOLLOSZY JO, Regulation of GLUT4 biogenesis in muscle: evidence for involvement of AMPK and Ca(2+). 2002. Am J Physiol Endocrinol Metab 282: E1008-1013.
108. OWEN MR,DORAN E AND HALESTRAP AP, Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. 2000. Biochem J 348 Pt 3: 607-614.
109. PEHMOLLER C, TREEBAK JT, BIRK JB, CHEN S, MACKINTOSH C, HARDIE DG,RICHTER EA AND WOJTASZEWSKI JF, Genetic disruption of AMPK signaling abolishes both contraction- and insulin-stimulated TBC1D1 phosphorylation and 14-3-3 binding in mouse skeletal muscle. 2009. Am J Physiol Endocrinol Metab 297: E665-675.
110. PHIELIX E,SZENDROEDI J AND RODEN M, The role of metformin and thiazolidinediones in the regulation of hepatic glucose metabolism and its clinical impact. 2011. Trends Pharmacol Sci 32: 607-616.
111. POWERS SK AND JACKSON MJ. 2008. Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production. Physiol Rev 88: 1243-1276.
112. RAZANI B, CHAKRAVARTHY MV AND SEMENKOVICH CF. 2008. Insulin resistance and atherosclerosis. Endocrinol Metab Clin North Am 37: 603-621, viii.
113. REICHKENDLER MH ET AL. 2013. Exercise training favors increased insulin-stimulated glucose uptake in skeletal muscle in contrast to adipose tissue: a randomized study using FDG PET imaging. Am J Physiol Endocrinol Metab 305: E496-506.
114. RENNIE MJ. 2007. Exercise- and nutrient-controlled mechanisms involved in maintenance of the musculoskeletal mass. Biochem Soc Trans 35: 1302-1305.
115. RICHTER EA,DERAVE W AND WOJTASZEWSKI JF, Glucose, exercise and insulin: emerging concepts. 2001. J Physiol 535: 313-322.
116. RICHTER EA AND HARGREAVES M. 2012. Exercise, GLUT4, and skeletal muscle glucose uptake. Physiol Rev 93: 9931017.
117. RICHTER EA, NIELSEN JN, JORGENSEN SB, FROSIG C,BIRK JB AND WOJTASZEWSKI JF, Exercise signalling to glucose transport in skeletal muscle. 2004. Proc Nutr Soc 63: 211-216.
118. RIZZA R AND BUTLER P. 1990. Insulin resistance in type II diabetes mellitus. Adv Second Messenger Phosphoprotein Res 24: 511-516.
119. ROBERTS CK, BARNARD RJ,SCHECK SH AND BALON TW, Exercise-stimulated glucose transport in skeletal muscle is nitric oxide dependent. 1997. Am J Physiol 273: E220-225.
120. ROTHMAN DL, MAGNUSSON I, CLINE G, GERARD D, KAHN CR,SHULMAN RG AND SHULMAN GI, Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. 1995. Proc Natl Acad Sci U S A 92: 983-987.
121. ROWLAND AF, FAZAKERLEY DJ AND JAMES DE. 2011. Mapping insulin/GLUT4 circuitry. Traffic 12: 672-681.
122. ROY D,PERREAULT M AND MARETTE A, Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent. 1998. Am J Physiol 274: E692-699.
123. SALT IP, JOHNSON G,ASHCROFT SJ AND HARDIE DG, AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic beta cells, and may regulate insulin release. 1998. Biochem J 335(3): 533-539.
124. SANDSTROM ME, ZHANG SJ, BRUTON J, SILVA JP, REID MB,WESTERBLAD H AND KATZ A, Role of reactive oxygen species in contraction-mediated glucose transport in mouse skeletal muscle. 2006. J Physiol 575: 251-262.
125. SANO H, KANE S, SANO E, MIINEA CP, ASARA JM, LANE WS,GARNER CW AND LIENHARD GE, Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. 2003. J Biol Chem 278: 14599-14602.
126. SANTOS JM, RIBEIRO SB, GAYA AR,APPELL HJ AND DUARTE JA, Skeletal muscle pathways of contraction-enhanced glucose uptake. 2008. Int J Sports Med 29: 785-794.
127. SARBASSOV DD, GUERTIN DA,ALI SM AND SABATINI DM, Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. 2005. Science 307: 1098-1101.
128. SCHULTZE SM, HEMMINGS BA,NIESSEN M AND TSCHOPP O, PI3K/AKT, MAPK and AMPK signalling: protein kinases in glucose homeostasis. 2012. Expert Rev Mol Med 14: e1.
129. SHAH AK,GUPTA A AND DEY CS, AICAR induced AMPK activation potentiates neuronal insulin signaling and glucose uptake. 2011. Arch Biochem Biophys 509: 142-146.
130. SHEIBANI S, HANACHI P AND REFAHIAT MA. 2012. Effect of Aerobic Exercise on Serum Concentration of Apelin, TNFalpha and Insulin in Obese Women. Iran J Basic Med Sci 15: 1196-1201.
131. SHEIBANI S, HANACHI P AND REFAHIAT MA. 2012. Effect of Aerobic Exercise on Serum Concentration of Apelin, TNFalpha and Insulin in Obese Women. Iran J Basic Med Sci 15: 1196-1201.
132. SHEPHERD PR ANDKAHN BB. 1999. Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus. N Engl J Med 341: 248-257.
133. SHIUCHI T, CUI TX, WU L, NAKAGAMI H,TAKEDA-MATSUBARA Y,IWAI M ANDHORIUCHI M, ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO. 2002. Hypertension 40: 329-334.
134. SHIUCHI T, NAKAGAMI H, IWAI M, TAKEDA Y, CUI T, CHEN R,MINOKOSHI Y ANDHORIUCHI M, Involvement of bradykinin and nitric oxide in leptin-mediated glucose uptake in skeletal muscle. 2001. Endocrinology 142: 608-612.
135. SRIWIJITKAMOL A AND MUSI N. 2008. Advances in the development of AMPK-activating compounds. Expert Opin Drug Discov 3: 1167-1176.
136. SZEKERES F, CHADT A, TOM RZ, DESHMUKH AS, CHIBALIN AV, BJORNHOLM M, H AL-HASANIAND ZIERATHJr. 2012. The Rab-GTPase-activating protein TBC1D1 regulates skeletal muscle glucose metabolism. Am J Physiol Endocrinol Metab 303: E524-533.
137. TANAKA T ET AL. 2003. Nitric oxide stimulates glucose transport through insulin-independent GLUT4 translocation in 3T3-L1 adipocytes. Eur J Endocrinol 149: 61-67.
138. TAYLOR EB ET AL. 2008. Discovery of TBC1D1 as an insulin-, AICAR-, and contraction-stimulated signaling nexus in mouse skeletal muscle. J Biol Chem 283: 9787-9796.
139. TERADA S,MURAOKA I AND TABATA I, Changes in [Ca2+]i induced by several glucose transport-enhancing stimuli in rat epitrochlearis muscle. 2003. J Appl Physiol 94: 1813-1820.
140. THONG FS,DUGANI CB ANDKLIP A, Turning signals on and off: GLUT4 traffic in the insulin-signaling highway. 2005. Physiology (Bethesda) 20: 271-284.
141. VAN DAM EM,GOVERS R AND JAMES DE, Akt activation is required at a late stage of insulin-induced GLUT4 translocation to the plasma membrane. 2005. Mol Endocrinol 19: 1067-1077.
142. VIOLLET B, GUIGAS B, SANZ GARCIA N, LECLERC J,FORETZ M AND ANDREELLI F, Cellular and molecular mechanisms of metformin: an overview. 2012. Clin Sci (Lond) 122: 253-270.
143. VOGT B, MUHLBACHER C, CARRASCOSA, J, OBERMAIER-KUSSER B, SEFFER E,MUSHACK J,PONGRATZ D AND HARING HU, Subcellular distribution of GLUT 4 in the skeletal muscle of lean type 2 (non-insulin-dependent) diabetic patients in the basal state. 1992. Diabetologia 35: 456-463.
144. WESTPHAL SA. 2008. Obesity, abdominal obesity, and insulin resistance. Clin Cornerstone 9: 23-29; discussion 30-21.
145. WHEATLEY CM, RATTIGAN S, RICHARDS SM,BARRETT EJ AND CLARK MG, Skeletal muscle contraction stimulates capillary recruitment and glucose uptake in insulinresistant obese Zucker rats. 2004. Am J Physiol Endocrinol Metab 287: E804-809.
146. WHITE MF AND KAHN CR. 1994. The insulin signaling system. J Biol Chem 269: 1-4.
147. WIJESEKARA N, TUNG A,THONG F AND KLIP A, Muscle cell depolarization induces a gain in surface GLUT4 via reduced endocytosis independently of AMPK. 2006. Am J Physiol Endocrinol Metab 290: E1276-1286.
148. WINDER WW AND HARDIE DG. 1996. Inactivation of acetyl CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. The American journal of physiology 270: E299-304.
149. WOJTASZEWSKI JF, MACDONALD C, NIELSEN JN, HELLSTEN Y, HARDIE DG, KEMP BE,KIENS B AND RICHTER EA, Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. 2003. American journal of physiology Endocrinology and metabolism 284: E813-822.
150. WRIGHT DC, GEIGER PC,HOLLOSZY JO AND HAN DH, Contraction- and hypoxia-stimulated glucose transport is mediated by a Ca2+-dependent mechanism in slow-twitch rat soleus muscle. 2005. Am J Physiol Endocrinol Metab 288: E1062-1066.
151. WRIGHT DC, HUCKER KA,HOLLOSZY JO AND HAN DH, Ca2+ and AMPK both mediate stimulation of glucose transport by muscle contractions. 2004. Diabetes 53: 330-335.
152. YE JM, DZAMKO N, HOY AJ, IGLESIAS MA,KEMP B AND KRAEGEN E, Rosiglitazone treatment enhances acute AMP-activated protein kinase-mediated muscle and adipose tissue glucose uptake in high-fat-fed rats. 2006. Diabetes 55: 2797-2804.
153. YOUN JH,GULVE EA AND HOLLOSZY JO, Calcium stimulates glucose transport in skeletal muscle by a pathway independent of contraction. 1991. Am J Physiol 260: C555-561.
154. ZANG M, ZUCCOLLO A, HOU X, NAGATA D, WALSH K, HERSCOVITZ H, BRECHER P,RUDERMAN NB AND COHEN RA, AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. 2004. J Biol Chem 279: 47898-47905.
155. ZHOU G ET AL. 2001. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108: 1167-1174.
156. ZIERATH Jr, HE L, GUMA A, ODEGOARD WAHLSTROM E, KLIP A AND WALLBERG-HENRIKSSON H. 1996. Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM. Diabetologia 39: 1180-1189.
157. ZOU MH, KIRKPATRICK SS, DAVIS BJ, NELSON JS, WILES WGT, SCHLATTNER U, NEUMANN D, BROWNLEE M,FREEMAN MB AND GOLDMAN MH, Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species. 2004. J Biol Chem 279: 43940-43951.